{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:55:56Z","timestamp":1793174156010,"version":"4.5.0"},"reference-count":42,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100016981","name":"Necmettin Erbakan University Scientific Research Projects Unit","doi-asserted-by":"publisher","award":["211218019"],"award-info":[{"award-number":["211218019"]}],"id":[{"id":"10.13039\/501100016981","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Atten Disord"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Blood-brain barrier permeability (BBB) has been suggested to be involved in the etiopathogenesis of ADHD. Claudin-5, \u03b2-catenin and paxillin are important molecules with different roles in this barrier. Alterations in these molecules may disrupt the neurodevelopmental process by affecting various critical processes in the developing brain. Therefore, this study aimed to evaluate whether the peripheral levels of these molecules differ in children and adolescents with ADHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>A total of 90 patients with ADHD aged between 8 and 18\u2009years and 60 healthy controls were included in this study. The severity of ADHD symptoms was determined with the Atilla Turgay Scale. Child Anxiety-Depression Scale-Revised was completed to evaluate additional psychiatric problems of the patients. Serum levels of biochemical parameters were measured using enzyme-linked immunosorbent assay kits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Serum claudin-5 levels were significantly lower and \u03b2-catenin levels were significantly higher in the ADHD group compared to the control group. However, there was no significant difference in paxillin serum levels between the groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study suggests that claudin-5 and beta-catenin may play a role in the pathogenesis of ADHD. These proteins may affect the brain by causing a dysregulation in BBB permeability or through other mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10870547251400398","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:35:33Z","timestamp":1765197333000},"page":"757-764","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Investigation of Tight Junction Protein Alterations in ADHD: The Role of Claudin-5, \u03b2-Catenin and Paxillin"],"prefix":"10.1177","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3381-2331","authenticated-orcid":false,"given":"Necati","family":"Uzun","sequence":"first","affiliation":[{"name":"Necmettin Erbakan University, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Bilgi\u00e7","sequence":"additional","affiliation":[{"name":"Izmir University of Economics, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hur\u015fit","family":"Ferahkaya","sequence":"additional","affiliation":[{"name":"Necmettin Erbakan University, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Berat","family":"Ta\u015f","sequence":"additional","affiliation":[{"name":"Karamano\u011flu Mehmet Bey University, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[{"name":"Necmettin Erbakan University, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Osman","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[{"name":"Necmettin Erbakan University, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Abu-Elfotuh K. Abdel-Sattar S. A. Abbas A. N. Mahran Y. F. Alshanwani A. R. Hamdan A. M. E. Atwa A. M. Reda E. Ahmed Y. M. Zaghlool S. S. El-Din M. N. (2022). The protective effect of thymoquinone or\/and thymol against monosodium glutamate-induced attention-deficit\/hyperactivity disorder (ADHD)-like behavior in rats: Modulation of Nrf2\/HO-1 TLR4\/NF-\u03baB\/NLRP3\/caspase-1 and Wnt\/\u03b2-Catenin signaling pathways in rat model. Biomedicine & Pharmacotherapy 155 Article 113799. https:\/\/doi.org\/10.1016\/j.biopha.2022.113799","DOI":"10.1016\/j.biopha.2022.113799"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2020.1801754"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/08039488.2023.2168055"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9603751"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Chandrakesan P. Jakkula L. U. M. R. Ahmed I. Roy B. Anant S. Umar S. (2013). Differential effects of \u03b2-catenin and NF-\u03baB interplay in the regulation of cell proliferation inflammation and tumorigenesis in response to bacterial infection. PLoS ONE 8(11) e79432. https:\/\/doi.org\/10.1371\/journal.pone.0079432","DOI":"10.1371\/journal.pone.0079432"},{"key":"e_1_3_3_8_1","doi-asserted-by":"crossref","unstructured":"Custodio R. J. P. Kim H. J. Kim J. Ortiz D. M. Kim M. Buctot D. Sayson L. V. Lee H. J. Kim B.-N. Yi E. C. Cheong J. H. (2023). Hippocampal dentate gyri proteomics reveals Wnt signaling involvement in the behavioral impairment in the THRSP-overexpressing ADHD mouse model. Communications Biology 6(1) 55. https:\/\/doi.org\/10.1038\/s42003-022-04387-5","DOI":"10.1038\/s42003-022-04387-5"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.018044"},{"key":"e_1_3_3_10_1","first-page":"132","article-title":"Development of a test battery for attention deficit hyperactivity disorder","volume":"8","author":"Ercan E. S.","year":"2001","unstructured":"Ercan E. S., Amado S., Somer O., \u00c7iko\u011flu S. (2001). Development of a test battery for attention deficit hyperactivity disorder. Turkish Journal of Child and Adolescent Mental Health, 8, 132\u2013144.","journal-title":"Turkish Journal of Child and Adolescent Mental Health"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Ferahkaya H. Ak\u00e7a \u00d6. F. Baysal T. K\u0131l\u0131n\u00e7 \u0130. (2024). Claudin-5 occludin zonulin and tricellulin levels of children with attention-deficit\/hyperactivity disorder. The European Journal of Psychiatry 38(1) Article 100225. https:\/\/doi.org\/10.1016\/j.ejpsy.2023.100225","DOI":"10.1016\/j.ejpsy.2023.100225"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Gormez V. K\u0131l\u0131n\u00e7aslan A. Orengul A. C. Ebesutani C. Kaya I. Ceri V. Nas\u0131roglu S. Filiz M. Chorpita B. (2017). Psychometric properties of the Turkish version of the Revised Child Anxiety and Depression Scale \u2013 Child Version in a clinical sample. Psychiatry and Clinical Psychopharmacology 27(1) 84\u201392. https:\/\/doi.org\/10.1080\/24750573.2017.1297494","DOI":"10.1080\/24750573.2017.1297494"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Greene C. Hanley N. Campbell M. (2019). Claudin-5: Gatekeeper of neurological function. Fluids and Barriers of the CNS 16(1) 3. https:\/\/doi.org\/10.1186\/s12987-019-0123-z","DOI":"10.1186\/s12987-019-0123-z"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"Greene C. Hanley N. Campbell M. (2020). Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders. Translational Psychiatry 10(1) 373. https:\/\/doi.org\/10.1038\/s41398-020-01054-3","DOI":"10.1038\/s41398-020-01054-3"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Greene C. Kealy J. Humphries M. M. Gong Y. Hou J. Hudson N. Cassidy L. M. Martiniano R. Shashi V. Hooper S. R. Grant G. A. Kenna P. F. Norris K. Callaghan C. K. Islam M. dN. O\u2019Mara S. M. Najda Z. Campbell S. G. Pachter J. S. . . . Campbell M. (2018). Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. Molecular Psychiatry 23(11) 2156\u20132166. https:\/\/doi.org\/10.1038\/mp.2017.156","DOI":"10.1038\/mp.2017.156"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/08039488.2020.1715474"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Kakogiannos N. Ferrari L. Giampietro C. Scalise A. A. Maderna C. Rav\u00e0 M. Taddei A. Lampugnani M. G. Pisati F. Malinverno M. Martini E. Costa I. Lupia M. Cavallaro U. Beznoussenko G. V. Mironov A. A. Fernandes B. Rudini N. Dejana E. Giannotta M. (2020). JAM-A acts via C\/EBP-\u03b1 to promote claudin-5 expression and enhance endothelial barrier function. Circulation Research 127(8) 1056\u20131073. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316742","DOI":"10.1161\/CIRCRESAHA.120.316742"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","unstructured":"Kaufman J. Birmaher B. Brent D. Rao U. Flynn C. Moreci P. Williamson D. Ryan N. (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child & Adolescent Psychiatry 36(7) 980\u2013988. https:\/\/doi.org\/10.1097\/00004583-199707000-00021","DOI":"10.1097\/00004583-199707000-00021"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.01.117"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","unstructured":"Lizano P. Pong S. Santarriaga S. Bannai D. Karmacharya R. (2023). Brain microvascular endothelial cells and blood-brain barrier dysfunction in psychotic disorders. Molecular Psychiatry 28(9) 3698\u20133708. https:\/\/doi.org\/10.1038\/s41380-023-02255-0","DOI":"10.1038\/s41380-023-02255-0"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Lv M. Zhang H. Shu Y. Chen S. Hu Y. Zhou M. (2016). The neonatal levels of TSB NSE and CK-BB in autism spectrum disorder from Southern China. Translational Neuroscience 7(1) 6\u201311. https:\/\/doi.org\/10.1515\/tnsci-2016-0002","DOI":"10.1515\/tnsci-2016-0002"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","unstructured":"Ma X. Hammes S. R. (2018). Paxillin actions in the nucleus. Steroids 133 87\u201392. https:\/\/doi.org\/10.1016\/j.steroids.2017.10.012","DOI":"10.1016\/j.steroids.2017.10.012"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2009.06.016"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","unstructured":"Maes M. Sirivichayakul S. Kanchanatawan B. Vodjani A. (2019). Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit Schizophrenia. Neurotoxicity Research 36(2) 306\u2013322. https:\/\/doi.org\/10.1007\/s12640-019-00054-6","DOI":"10.1007\/s12640-019-00054-6"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","unstructured":"Maguschak K. A. Ressler K. J. (2012). The dynamic role of beta-catenin in synaptic plasticity. Neuropharmacology 62(1) 78\u201388. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.032","DOI":"10.1016\/j.neuropharm.2011.08.032"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","unstructured":"McCullumsmith R. E. Gupta D. Beneyto M. Kreger E. Haroutunian V. Davis K. L. Meador-Woodruff J. H. (2007). Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophrenia Research 90(1\u20133) 15\u201327. https:\/\/doi.org\/10.1016\/j.schres.2006.11.017","DOI":"10.1016\/j.schres.2006.11.017"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00083"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21850"},{"issue":"1","key":"e_1_3_3_29_1","first-page":"79","article-title":"Polymorphism of the CLDN5 gene and schizophrenia in an Iranian population","volume":"43","author":"Omidinia E.","year":"2014","unstructured":"Omidinia E., Mazar F. M., Shahamati P., Ianmehr A., Mohammadi H. S. (2014). Polymorphism of the CLDN5 gene and schizophrenia in an Iranian population. Iranian Journal of Public Health, 43(1), 79.","journal-title":"Iranian Journal of Public Health"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","unstructured":"Pai S. G. Carneiro B. A. Mota J. M. Costa R. Leite C. A. Barroso-Sousa R. Kaplan J. B. Chae Y. K. Giles F. J. (2017). Wnt\/beta-catenin pathway: Modulating anticancer immune response. Journal of Hematology & Oncology 10(1) 101. https:\/\/doi.org\/10.1186\/s13045-017-0471-6","DOI":"10.1186\/s13045-017-0471-6"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12228"},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","unstructured":"Polanczyk G. V. Salum G. A. Sugaya L. S. Caye A. Rohde L. A. (2015). Annual Research Review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. Journal of Child Psychology and Psychiatry 56(3) 345\u2013365. https:\/\/doi.org\/10.1111\/jcpp.12381","DOI":"10.1111\/jcpp.12381"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","unstructured":"Santos R. Linker S. B. Stern S. Mendes A. P. D. Shokhirev M. N. Erikson G. Randolph-Moore L. Racha V. Kim Y. Kelsoe J. R. Bang A. G. Alda M. Marchetto M. C. Gage F. H. (2021). Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients. Molecular Psychiatry 26(6) 2440\u20132456. https:\/\/doi.org\/10.1038\/s41380-020-00981-3","DOI":"10.1038\/s41380-020-00981-3"},{"key":"e_1_3_3_34_1","doi-asserted-by":"crossref","unstructured":"Tanir Y. Orengul A. C. Ozdemir Y. E. Karayagmurlu A. Bilbay Kaynar T. Baki A. M. Vural P. Coskun M. (2023). Serum Zonulin and Claudin-5 but not interferon-gamma and interleukin-17A levels increased in children with specific learning disorder: A case\u2013control study. Psychiatry and Clinical Psychopharmacology 33 211\u2013217. https:\/\/doi.org\/10.5152\/pcp.2023.23660","DOI":"10.5152\/pcp.2023.23660"},{"key":"e_1_3_3_35_1","doi-asserted-by":"crossref","unstructured":"Teo C. H. Soga T. Parhar I. S. (2018). Brain beta-catenin signalling during stress and depression. Neurosignals 26(1) 31\u201342. https:\/\/doi.org\/10.1159\/000487764","DOI":"10.1159\/000487764"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00238-X"},{"issue":"3","key":"e_1_3_3_37_1","first-page":"118","article-title":"Diagnosis of patients referring to a child and adolescent psychiatry outpatient clinic","volume":"30","author":"T\u00fcrko\u011flu S.","year":"2014","unstructured":"T\u00fcrko\u011flu S. (2014). Diagnosis of patients referring to a child and adolescent psychiatry outpatient clinic. Selcuk Medical Journal, 30(3), 118\u2013122.","journal-title":"Selcuk Medical Journal"},{"issue":"1","key":"e_1_3_3_38_1","first-page":"42","article-title":"Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T)","volume":"30","author":"\u00dcnal F.","year":"2019","unstructured":"\u00dcnal F., \u00d6ktem F., \u00c7etin \u00c7uhadaro\u011flu F., \u00c7engel K\u00fclt\u00fcr S. E., Akdemi D., Foto \u00d6zdemir D., Kalayci B. M. (2019). Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T). Turkish Journal of Psychiatry, 30(1), 42\u201350.","journal-title":"Turkish Journal of Psychiatry"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","unstructured":"Usta A. K\u0131l\u0131\u00e7 F. Demirda\u015f A. I\u015f\u0131k \u00dc. Do\u011fu\u00e7 D. K. Bozkurt M. (2021). Serum zonulin and claudin-5 levels in patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 271(4) 767\u2013773. https:\/\/doi.org\/10.1007\/s00406-020-01152-9","DOI":"10.1007\/s00406-020-01152-9"},{"key":"e_1_3_3_40_1","doi-asserted-by":"crossref","unstructured":"Vall\u00e9e A. (2022). Neuroinflammation in schizophrenia: The key role of the WNT\/\u03b2-catenin pathway. International Journal of Molecular Sciences 23(5) 2810. https:\/\/doi.org\/10.3390\/ijms23052810","DOI":"10.3390\/ijms23052810"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00999-9"},{"issue":"10","key":"e_1_3_3_42_1","first-page":"11981","article-title":"The correlation between LncRNA-17A expression in peripheral blood mononuclear cells and Wnt\/\u03b2-catenin signaling pathway and cognitive function in patients with Alzheimer disease","volume":"13","author":"Zhang C.","year":"2021","unstructured":"Zhang C., Li B. (2021). The correlation between LncRNA-17A expression in peripheral blood mononuclear cells and Wnt\/\u03b2-catenin signaling pathway and cognitive function in patients with Alzheimer disease. American Journal of Translational Research, 13(10), 11981\u201311986.","journal-title":"American Journal of Translational Research"},{"key":"e_1_3_3_43_1","doi-asserted-by":"crossref","unstructured":"Zhuang W. Ye T. Wang W. Song W. Tan T. (2023). CTNNB1 in neurodevelopmental disorders. Frontiers in Psychiatry 14 Article 1143328. https:\/\/doi.org\/10.3389\/fpsyt.2023.1143328","DOI":"10.3389\/fpsyt.2023.1143328"}],"container-title":["Journal of Attention Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10870547251400398","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10870547251400398","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10870547251400398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:30:46Z","timestamp":1777491046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10870547251400398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1177\/10870547251400398"],"URL":"https:\/\/doi.org\/10.1177\/10870547251400398","relation":{},"ISSN":["1087-0547","1557-1246"],"issn-type":[{"value":"1087-0547","type":"print"},{"value":"1557-1246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}